Remy Kesrouani
Angel Investor @ Kadmos Capital
London, United Kingdom
Remy Kesrouani is a seed investor at Kadmos Capital in London focused on Health Care and Biotechnology. Remy has over a decade of Investment Banking experience. He headed a Credit trading team at Morgan Stanley until 2012 and had previously worked at JP Morgan, Bear Stearns and Credit Lyonnais in several positions ranging from Credit Trading to Equity Research and Quantitative Analyst. Since 2012, Remy has been very active in the London Start-Upecosystem and has invested in, mentored and supported several early stage start-ups. Remy holds an MSC in Financial Mathematics from CASS Business School and a B.A. in Economics.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 71%
Last updated:
For AI agents: llms.txt
Industries Remy Kesrouani invests in
Stages Remy Kesrouani invests in
Countries Remy Kesrouani invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 3 (43%)
- Biotechnology 2 (29%)
- Financial Services 2 (29%)
- Fashion 1 (14%)
- FinTech 1 (14%)
Stage
- Seed 5 (71%)
- Pre-Seed 1 (14%)
- Series A 1 (14%)
Country
- United Kingdom 5 (71%)
- Luxembourg 1 (14%)
- The Netherlands 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Big Picture Bio is a developer of an AI-driven platform designed to identify, design, and optimize cancer combination therapies. | $2M / Pre-Seed / Sep 17, 2026 | ||
| Scindo is a cleantech start-up harnessing the power of enzymes to recycle the unrecyclables. We are targeting plastics that cannot be efficiently recycled with current methodologies, to turn them into high-value molecules that can be used in a plethora of industries. We are creating a more circular economy for plastics by developing an alternativeto landfills and incineration. | $5.4M / Seed / Sep 23, 2025 | ||
| Protocol for secure offline communication for Windows, iOS and Android. | $2.5M / Seed / Jun 19, 2025 | ||
| MDSIM is a health-tech startup. The companyon uses computer modeling and simulation (CM&S) in conjunction with data sciences and AI to assist improve the quality of life of millions of patients worldwide. | $2.6M / Seed / Jun 04, 2025 | ||
| Arda Biomaterials transforms waste feedstocks into smarter, circular biomaterials for fashion, home goods, automotive and more. | $5.3M / Seed / Apr 29, 2025 | ||
| Funding Xchange is transforming and connecting the SME funding eco-system through digital eligibility and affordability assessment tools. Funding Xchange built its leading technology platform by connecting businesses with more than 70 funders to access indicative offers in 3 minutes and money in businesses’ bank accounts in 10 minutes.Funding Xchange’s Marketplace provides access to finance where businesses are engaging with their finance. Using its API-led technology, Funding Xchange is embedding its Marketplace in the largest Price Comparison Websites like MoneySuperMarket, delivering custom marketplaces to banks like NatWest and Monzo, integrating finance solutions in advisory platforms like Enterprise Nation and finance available within accounting software and payment providers own eco-system. Through FXE Technologies, the business white-labels its intelligent SME lending tools for banks, funders and brokers. Clients are able to deploy white-labelled, digitally-led customer journeys and market-facing intermediary portals, transforming operating costs and increasing look-to-book ratios while also empowering active portfolio risk management.The tools are powered by real-time access to validated transactional data and leverage insights into risk analytics and underwriting across a broad spectrum of SME funding solutions. The eligibility and affordability tools deliver the benefits of digital transformation without the risk of complex and costly technology projects. Funding Xchange was founded in 2014 and is based in London, England, United Kingdom. | $2.1M / Series A / Mar 20, 2018 | ||
| Cygnetise is a SaaS application that makes the process of managing authorised signatory lists efficient and secure. Clients include Bacardi, Union Banque Priveé, National Rail, Willis Towers Watson, JTC, Raymond James, ADNOC, Evelyn and SEI | $1.3M / Seed / Oct 30, 2017 |
Co-Investors
About Kadmos Capital
Kadmos Capital is an investment firm.
Kadmos Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
John Gebeily
Operating Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Remy Kesrouani invest in?
Remy Kesrouani invests primarily in Health Care, Biotechnology and Financial Services startups, most often at Seed and Pre-Seed stage. Most of the 7 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Remy Kesrouani?
Public channels for Remy Kesrouani include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Remy Kesrouani last invest?
The most recent investment recorded for Remy Kesrouani closed in Sep 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
